Skip to main content
Equibles

BARCLAYS PLC

Position in XGN — Exagen Inc.

CIK 312069 LONDON, X0
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$25,542
-$38,139 QoQ
Shares Held
5,493
-74.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 57 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,657,623,631 across 35 Diagnostics & Research names. XGN ranks #31 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 1,354,112 $678,897,590
2 DHR
Danaher Corp /De/
 1,196,342 $227,879,222
3 MTD
Mettler Toledo International Inc/
 106,633 $136,224,722
4 DGX
Quest Diagnostics Inc
 448,726 $95,107,473
5 A
Agilent Technologies, Inc.
 714,580 $94,917,659
6 IDXX
Idexx Laboratories Inc /De
 148,839 $78,354,800
7 QGEN
Qiagen N.V.
 1,433,563 $56,052,312
8 WAT
Waters Corp /De/
 146,573 $54,970,737

All Filings in XGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,542 5,493
2026-03-31 $63,681 21,227
2025-12-31 $143,493 23,601
2025-09-30 $83,919 7,636
2025-06-30 $35,912 5,145
2025-03-31 $18,470 5,145
2024-12-31 $21,094 5,145
2024-09-30 $15,898 5,145
2024-06-30 $9,363 5,145
2024-03-31 $8,180 5,145
2023-12-31 $10,238 5,145
2023-09-30 $12,450 5,145
2023-06-30 $14,920 5,145
2023-03-31 $12,502 5,145
2022-12-31 $12,348 5,145
2022-09-30 $14,135 5,216
2022-06-30 $29,939 5,216
2022-03-31 $56,739 7,066